Symbol="VNDA"
AssetType="Common Stock"
Name="Vanda Pharmaceuticals Inc"
Description="Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia."
CIK="1347178"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="334325000"
EBITDA="12287000"
PERatio="20.79"
PEGRatio="-2.42"
BookValue="9.39"
DividendPerShare="0"
DividendYield="0"
EPS="0.28"
RevenuePerShareTTM="4.187"
ProfitMargin="0.0625"
OperatingMarginTTM="0.0406"
ReturnOnAssetsTTM="0.0097"
ReturnOnEquityTTM="0.0284"
RevenueTTM="238354000"
GrossProfitTTM="230100000"
DilutedEPSTTM="0.28"
QuarterlyEarningsGrowthYOY="-0.419"
QuarterlyRevenueGrowthYOY="-0.285"
AnalystTargetPrice="7"
TrailingPE="20.79"
ForwardPE="30.3"
PriceToSalesRatioTTM="1.532"
PriceToBookRatio="1.153"
EVToRevenue="0.586"
EVToEBITDA="13.6"
Beta="0.678"
num_52WeekHigh="11.05"
num_52WeekLow="5.45"
num_50DayMovingAverage="6.26"
num_200DayMovingAverage="7.41"
SharesOutstanding="57444000"
DividendDate="None"
ExDividendDate="None"
symbol="VNDA"
open="5.88"
high="5.90"
low="5.74"
price="5.82"
volume="894506.00"
latest_trading_day="2023-08-07"
previous_close="5.86"
change="-0.04"
change_percent="-0.6826%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="601760"
Change_recent_avg="-0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="99"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_negative_thumbnail_id_2="1164"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="958"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0120.jpeg"
image_positive_thumbnail_id_2="979"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
